Navigation Links
XYMOGEN Named Among The Nation's Fastest Growing Private Companies For The Sixth Time
Date:9/4/2013

ORLANDO, Fla., Sept. 4, 2013 /PRNewswire/ -- Orlando-based health-sciences company XYMOGEN announced today that it has been ranked for the sixth time to Inc. Magazine's Inc. 5000 list, which recognizes the fastest growing, most innovative, inspiring and best-run private companies in the nation. 

Inc. Magazine compiles the annual list based on revenue growth over a three-year period.  XYMOGEN is listed alongside such prominent brands as LivingSocial, Edible Arrangements and Zappos and is one of 33 Central Florida-based organizations to have made the 2013 lineup.  As a six-time honoree, XYMOGEN is part of an exclusive group known as the Honor Roll Alumni, a select circle of businesses to have made the list at least five times.

With 85 percent revenue growth and over 200 jobs added since 2012, XYMOGEN is one of few companies to thrive during a tough economic time.  The company attributes its continuous praises and accolades to a solid company culture and a team of passionate employees.

"This honor is truly a testament to the hard work and dedication of the XYMOGEN family," said CEO Brian Blackburn. "The company's continued growth and success is a reflection of the innovation and customer-focused mentality that our employees work toward every day."

XYMOGEN has over a quarter century of experience in providing quality professional supplements to healthcare practitioners.  The independent health sciences company has also introduced numerous innovations to the medical community. 

About XYMOGEN

XYMOGEN, a family-owned, health sciences company with headquarters in Orlando, Fla., has been providing high-quality dietary supplements to licensed health care practitioners for more than a quarter century.

The nutraceutical company has introduced numerous innovations to the functional medicine community; its Medical Board of Advisors consists of clinical practitioners who represent a broad range of specialties. XYMOGEN's unprecedented growth continues with a strategic international expansion, which includes Canada and Australia, two of the largest international markets.

XYMOGEN's strength as a company was reinforced in 2007, 2008, 2010, 2011, 2012 and 2013 when it was recognized by Inc. Magazine as one of the 5,000 fastest-growing (best run, most innovative and most inspiring) private companies in America.

The company's 136,000-square-foot manufacturing facility is GMP (good manufacturing practices) and GMP for Sport Athletic Banned Substances Program registered by NSF International.

More information is available at www.xymogen.com.

Please email pr@xymogen.com for comments or inquiries.

Distributed by Sara Brady Public Relations, Inc.
222 W. Comstock Avenue, Suite 215
Winter Park, Florida  32789
www.sarabradypr.com

For information, contact:
Kristin Colville 
407-702-6634

 


'/>"/>
SOURCE XYMOGEN
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PTS, Inc. Named to Inc. 500/5000 Fastest Growing Private Companies for Third Time
2. Philadelphia Business Journal has named Hope Paige Medical ID one of its Best Places to Work in Philadelphia
3. USANA Named One Of Americas Best Places To Work By Outside Magazine For 5th Consecutive Year
4. ChanTest CEO named Distinguished Service Award recipient by the Safety Pharmacology Society
5. Roger Graham Named President of Mylan Specialty
6. Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings
7. Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS
8. Baby Eva Named After Pioneering IVF Test
9. Comprehensive Care Corporation CEO Clark A. Marcus Named to Board of Americas Agenda: Health Care for All
10. Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
11. Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... The global  anxiety disorders and depression treatment market  is ... incidence of depression worldwide is anticipated to drive the market growth in the ... demand for antidepressants in the recent years. Continue ... ... ...
(Date:1/23/2017)... 23 janvier 2017  ResMed (NYSE : RMD), BMC (Pékin, ... ont annoncé aujourd,hui qu,ils se sont mis d,accord sur ... les parties. BMC et 3B seront autorisés à vendre ... à ResMed, et ResMed effectuera le paiement de la ... le litige de Floride entre les deux parties. Le ...
(Date:1/23/2017)... DIEGO , 23. Januar 2017  ResMed (NYSE: ... ) und 3B Medical ( Winter Haven, ... auf eine Vereinbarung über die Beilegung aller globalen Rechtsstreitigkeiten ... der Verkauf ihrer bestehenden Produkte im Tausch ... einmalige Zahlung an 3B leisten, um das in ...
Breaking Medicine Technology:
(Date:1/23/2017)... ... 23, 2017 , ... “Some Infallible Characteristics of Christ”: a fascinating and ... Christ” is the creation of published author, Rev. Dr. Robert W. Thomas, the third ... a preacher for over nineteen, a pastor for over fifteen years. He is a ...
(Date:1/22/2017)... TX (PRWEB) , ... January 22, 2017 , ... ... provide slow results. Often the results of a simple test will take days to ... Any Lab Test Now offers customers direct access to their lab tests, bypassing the ...
(Date:1/21/2017)... ... ... Phytocéane invites you to take an exotic journey deep into ... ZANZIBAR SHOWER GEL. Inspired by the beauty of Zanzibar, a Tanzanian archipelago off the ... coral to create this gentle, crystal-clear shower gel to cleanse the body and promote ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel Biocare™ dental ... in media for its creos™ line of bone regenerative products. Specifically, the ... which he utilizes creos™ allo.gain™ bone graft for a variety of bone reconstruction ...
(Date:1/20/2017)... ... 20, 2017 , ... Doctor C LLC, a company based out of Arizona ... to continue the marketing and distribution of its product, The Right C. , The ... better absorption than traditional vitamin C supplements. At the trade show, Doctor C had ...
Breaking Medicine News(10 mins):